1402047-78-2

Basic information

• Product Name: C₁₇H₂₄N₂O₂
• Synonyms: C₁₇H₂₄N₂O₂
• CAS NO: 1402047-78-2
• Molecular Weight: 288.39
• Mol File: 1402047-78-2.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: C₁₇H₂₄N₂O₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₇H₂₄N₂O₂(1402047-78-2)
• EPA Substance Registry System: C₁₇H₂₄N₂O₂(1402047-78-2)

Safety Data

• Hazardous Substances Data: 1402047-78-2(Hazardous Substances Data)

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 100-46-9 benzylamine 

Downstream Products

• 206273-87-2 4-benzylamino-piperidine-1-carboxylic acid tert-butyl ester 
• 1357353-34-4 C₂₀H₃₀N₂O₃ 
• 1402047-79-3 tert-butyl 4-(benzylamino)-4-(trifluoromethyl)piperidine-1-carboxylate 
• 1402047-77-1 tert-butyl 4-amino-4-(trifluoromethyl)piperidine-1-carboxylate hydrochloride 
• 1402047-72-6 tert-butyl 4-(trifluoromethyl)-4-(2,4,6-trimethylbenzamido)-piperidine-1-carboxylate 
• 328233-01-8 N-benzyl-N-(1-tert-butoxycarbonyl-1,2,3,6-tetrahydropyridin-4-yl)-2-iodobenzamide 
• 1266218-37-4 C₂₉H₃₆N₂O₂ 

Relevant articles and documents

Synthesis and Biological Evaluation of Fentanyl Analogues Modified at Phenyl Groups with Alkyls

A series of fentanyl analogues modified at the phenyl group of the phenethyl with alkyl and/or hydroxyl and alkoxy, and the phenyl group in the anilido moiety replaced with benzyl or substituted benzyl, were synthesized. The in vitro opioid receptor functional activity of these compounds was evaluated by assessment of their ability to modulate forskolin-stimulated cAMP accumulation and by their ability to induce β-arrestin2 recruitment. Compound 12 is a potent μ-opioid (MOP) receptor agonist, a potent κ-opioid (KOP) receptor antagonist with weak β-arrestin2 recruitment activity. Compounds 10 and 11 are potent MOP receptor agonists with weak δ-opioid (DOP) receptor antagonist activity and moderate KOP receptor antagonist activity as well as weak β-arrestin2 recruitment activity at the MOP receptor. These compounds are promising leads for discovery of potent opioid analgesics with reduced side effects relative to clinically available strong opioid analgesics.

Fentanyl analogue and application thereof

The invention discloses a fentanyl analogue and application thereof. A general structural formula of a compound is as follows (described in the following description), wherein R1 is a hydrogen group,a methyl group, a hydroxyl group, a methoxyl group, a halogen and a cyano group, and R2 is a phenyl group, a benzyl group and 3,5-benzyldimethyl. The compound provided by the invention embodies the activating effect of a mu-opioid receptor and the recruitment function of weak beta-arrestin 2, and therefore, the compound can be used as an analgesic drug and can overcome the respiration inhibition effect caused by activating a beta-arrestin 2 signal pathway.

Facile synthesis of sterically hindered and electron-deficient secondary amides from isocyanates

The big easy: The direct coupling of Grignard reagents to isocyanates provides a facile and robust solution for the synthesis of sterically hindered and electron-deficient secondary amides. The products are obtained in high yields without the need for excess reagents or chromatographic purification. Copyright